The ENT endoscopes market is driven by the new-generation flexible video scopes.These are less traumatic and provide improved visualization for the surgeons. The increasing cases of sinusitis, ear infections, and sleep disorders are driving the growth of the ENT endoscopes market. Obesity and older adult population contribute to the increasing use of these devices. Surgeries related to the head and neck region that are inaccessible for surgeries are expected to increase over the forecast period. These surgeries include transnasal endoscopic pituitary gland surgery, tumor resection, and complex ear surgery. However, the preference for non-invasive procedures such as Positron Emission Tomography (PET) and other imaging technologies challenge the market growth for ENT endoscopes. Olympus is the leading manufacturer of these devices followed by Karl Storz and Arthrex.The bronchoscopes market is driven by the increasing cases of chronic obstructive pulmonary disease (COPD), the major indication for the use of bronchoscopes. As per Centers for Disease Control and Prevention (CDC) statistics, in the US, 6.4% of the total population were diagnosed with COPD in 2014. The age group between 65-74 years were majorly diagnosed out of the total population. The other causative factors for respiratory infections are smoking and air pollution. Olympus and Karl Storz are the leading manufacturers of bronchoscopes.

PART 01: Executive summary 6

PART 02: Scope of the report 17

PART 03: Research Methodology 22

PART 04: Introduction 25

Key market highlights 25

PART 05: Market landscape 27

Market overview 27

Market size and forecast 28

Five forces analysis 30

Market overview 30

PART 06: Market segmentation by product 31

PART 07: Market segmentation by end-user 36

Hospitals and clinics 36

ASCs 38

POLs 40

PART 08: Geographical segmentation 42

ENT endoscopic and bronchoscopic devices market in

Americas 43

ENT endoscopic and bronchoscopic devices market in

EMEA 46

ENT endoscopic and bronchoscopic devices market in

APAC 48

PART 09: Market drivers 50

Growing elderly population with respiratory disorders 50

Strong presence of third-party service providers driving

endoscopic devices market 51

Increasing preference for MI procedures 52

M&A increasing the service networks 52

PART 10: Impact of drivers 53

PART 11: Market challenges 54

Superbug outbreak a major challenge to the

manufacturers 54

Alternative treatment options hindering the progress of

ENT endoscopes 54

Dynamic market shift due to increasing control of GPOs

over device pricing in the US 55

Lack of trained and certified physicians to perform MI

procedures 55

PART 12: Impact of drivers and challenges 56

PART 13: Market trends 57

Increasing preference for endoscopic middle ear

surgery 57

Image-guided bronchoscopy for treating PPLs 57

PART 14: Vendor landscape 59

Competitive scenario 59

PART 15: Key vendor analysis 61

Aesculap 61

Teleflex 64

Karl Storz 67

Olympus 70

Other prominent vendors 73

PART 16: Appendix 74

List of abbreviations 74

PART 17: Explore Technavio 75